I can speak to the question about me. Roger, perhaps, could do the second part.
You're right that it's very similar to what we do for journals. For every trial that we publish the results for, for every talk that we give, particularly in a university, we have to have a slide that lists every company our employer has had a relationship with. For me, for example, I'm a professor at a university, at Dalhousie. I'm an employee of the university. When we do clinical trials here at the Canadian Center for Vaccinology, some of our funding would be from CIHR and some of it might be from a company like Janssen doing a phase one trial. We'd negotiate a contract—it would be the university with the company—and then the money would be used to pay the research nurses we have and so on.
None of the money in Canada, when you do those kinds of clinical trials, goes to investigators, at least when you're in an academic setting. I think that answers the Janssen part. We had previously done Janssen studies—